Get Email Alerts
Receive email updates about meeting announcements. Learn more.
|
NHLBI Symposium on Cardiovascular Regenerative Medicine
Agenda
Preliminary Agenda
Wednesday, September 25, 3013
Welcome and Opening Remarks
Manfred Boehm, M.D.
National Heart, Lung, and Blood Institute
Gary H. Gibbons, M.D.
National Heart, Lung, and Blood Institute
Session I: General Stem Cells
Moderator: Jonathan A. Epstein, M.D., Ph.D.,
Perelman School of Medicine, University of Pennsylvania
Disease Modeling With iPS Cells
George Q. Daley, M.D., Ph.D.
Children’s Hospital Boston and Harvard Medical School
Insights Into Reprogramming to Pluripotency
Kathrin Plath, Ph.D.
University of California, Los Angeles
ES Cells, iPS Cells and Disease Modeling: Technical Challenges
Rudolph Jaenisch, M.D.
Whitehead Institute / Massachusetts Institute of Technology
Questions & Answers
Break
Session II: Cardiovascular Stem Cells
Moderator: John P. Cooke, M.D., Ph.D.
Stanford University School of Medicine
Reprogramming Approaches to Cardiovascular Disease
Deepak Srivastava, M.D.
Gladstone Institute of Cardiovascular Disease and University of California, San Francisco
Regulation of Developmental Cardiac Progenitor Cell Commitment and Multi-lineage Differentiation
Sean M. Wu, M.D., Ph.D.
Stanford University School of Medicine
Regenerating the Heart of a Non-Human Primate
Charles E. Murry, Ph.D., M.D.
University of Washington
Cardiac iPSCs for Disease Modeling and Drug Screening
Joseph C. Wu, M.D., Ph.D.
Stanford University School of Medicine
Questions & Answers
Lunch (on your own)
Session III: Tissue Engineering
Moderator: Amy Wagers, Ph.D.
Joslin Diabetes Center / Harvard University
Forces, Form, and Regenerating Function
Christopher S. Chen, M.D., Ph.D.
University of Pennsylvania School of Engineering and Applied Science
New Cardiomyocytes: From Progenitors, or Existing Cardiomyocytes?
Richard T. Lee, M.D.
Harvard Medical School and Brigham and Women’s Hospital
Acellular Arterial Conduits
Laura E. Niklason, M.D., Ph.D.
Yale University School of Engineering and Applied Sciences
Questions & Answers
Adjourn
Poster Session
Thursday, September 26, 2013
Session IV: NIH Support for Stem Cell Research
Moderator: Robert D. Simari, M.D.
Mayo Clinic
NIH Intramural Perspective
Mahendra S. Rao, M.D., Ph.D.
NIH Center for Regenerative Medicine
NEXT Gen
Cashell Jaquish, Ph.D.
NHLBI Division of Cardiovascular Sciences
NHLBI Progenitor Cell Biology Consortium
Denis B. Buxton, Ph.D.
NHLBI Division of Cardiovascular Sciences
Building the Foundation: The NHLBI Lung Repair and Regeneration Consortium
Carol Blaisdell, Ph.D.
NHLBI Division of Lung Diseases
Questions & Answers
Break
Session V: Clinical Applications
Moderator: Jason C. Kovacic, M.D., Ph.D.
Mt. Sinai School of Medicine
Stem Cell Therapy for Peripheral Arterial Disease: Limping Along or on PACE?
John P. Cooke, M.D., Ph.D.
Stanford Cardiovascular Institute / Stanford University School of Medicine
Future Directions of the NHLBI-sponsored CCTRN
Robert D. Simari, M.D.
Mayo Clinic
Use of Cardiac Stem Cells for the Treatment of Ischemic Cardiomyopathy: The SCIPIO Trial
Roberto Bolli, M.D.
University of Louisville
New Approaches to Cell Products for Cardiac Cell-based Therapy
Joshua M. Hare, M.D.
University of Miami Miller School of Medicine
Questions & Answers
Lunch
Session VI: Developmental Biology
Moderator: Sean M. Wu, M.D., Ph.D.
Stanford University School of Medicine
Epigenetic Regulation of Cardiac Differentiation
Benoit G. Bruneau, Ph.D.
Gladstone Institute of Cardiovascular Disease / University of California, San Francisco
Hopx and Cardiac Progenitors
Jonathan A. Epstein, M.D.
University of Pennsylviania Perelman College of Medicine
Strategies to Reverse Age-related Dysfunction in the Cardiovascular System
Amy Wagers, Ph.D.
Harvard University/Joslin Diabetes Center
Guidance of Vascular Patterning
Anne Eichmann, Ph.D., M.Sc.
Yale University School of Medicine
Questions & Answers
Session VII: Proteomics/Metabolomics
Moderator: George Q.Daley, M.D., Ph.D.
Children's Hospital Boston / Harvard Medical School
A Self-Sustaining Feedback Loop That Regulates Proteome Diversity and Supports Self-renewal
in Pluripotent Stem Cells
Jarrod A. Marto, Ph.D.
Dana-Farber Cancer Institute/Harvard Medical School
Generating New Therapeutics for Myocardial Regeneration and Protection
Mark Mercola, Ph.D.
Sanford Burnham Medical Research Institute/University of California, San Diego
New Biological Insights Through Human iPS Cell-derived Hepatocytes
Daniel J. Rader, M.D.
University of Pennsylvania Perelman College of Medicine
Assessing Stem and Progenitor Cell Utility: The Proteomics of the Cell-environment Interface
Jennifer Van Eyk, Ph.D.
Johns Hopkins School of Medicine
Questions & Answers
Closing Remarks
Manfred Boehm, M.D.
National Heart, Lung, and Blood Institute
Adjournment
Twitter
Facebook
YouTube
Google+